Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: A HuGE review

American Journal of Epidemiology

Volumn 156, Issue 10, 2002, Pages 885-902

  Mitchell, R J ^a   Farrington, S M ^b   Dunlop, M G ^b   Campbell, H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Colorectal neoplasms; Epidemiology; Genetic screening; Germ line mutation; hMLH1; hMSH2; Penetrance; Survival

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2;

CANCER; GENETIC STRUCTURE; SURVIVAL;

CANCER GENETICS; COLORECTAL CANCER; GENE INTERACTION; GENE MUTATION; HETEROZYGOTE; HUMAN; LINKAGE ANALYSIS; MASS SCREENING; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MOLECULAR BIOLOGY; REVIEW; RISK ASSESSMENT; SEGREGATION ANALYSIS; SEX DIFFERENCE;

BASE PAIR MISMATCH; CARRIER PROTEINS; CHROMOSOME MAPPING; CHROMOSOME SEGREGATION; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; MALE; MOLECULAR BIOLOGY; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PENETRANCE; PHENOTYPE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX FACTORS; VARIATION (GENETICS);

EID: 0037111578     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwf139     Document Type: Review

References (125)

1. International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. ICG-HNPCC Mutation Database. Leiden, The Netherlands: International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer, 2001. (World Wide Web URL: http://www.nfdht.nl/).
2. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.
3. Peltomaki P, Aaltonen LA, Sistonen P, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993;260:810-12.
4. Modrich P. Mechanisms and biological effects of mismatch repair. Annu Rev Genet 1991;25:229-53.
5. Lindblom A, Tannergard P, Werelius B, et al. Genetic mapping of a second locus predisposing to hereditary nonpolyposis colon cancer. Nature Genet 1993;5:279-82.
6. Nystrom-Lahti M, Sistonen P, Mecklin JP, et al. Close linkage to chromosome 3p and conservation of ancestral founding haplotype in hereditary nonpolyposis colorectal cancer families. Proc Natl Acad Sci U S A 1994;91:6054-8.
7. Nystrom-Lahti M, Holmberg M, Fidalgo P, et al. Missense and nonsense mutations in codon 659 of MLH1 cause aberrant splicing of messenger RNA in HNPCC kindreds. Genes Chromosomes Cancer 1999;26:372-5.
8. Ellison AR, Lofing J, Bitter GA. Functional analysis of human MLH1 and MSH2 missense variants and hybrid human-yeast MLH1 proteins in Saccharomyces cerevisiae. Hum Mol Genet 2001;10:1889-900.
9. Nystrom-Lahti M, Perrera C, Raschle M, et al. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer. Genes Chromosomes Cancer 2002;33:160-7.
10. Trojan J, Zeuzem S, Randolph A, et al. Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. Gastroenterology 2002;122:211-19.
11. Wijnen J, van der KH, Vasen H, et al. MSH2 genomic deletions are a frequent cause of HNPCC. (Letter). Nature Genet 1998;20:326-8.
12. Nystrom-Lahti M, Wu Y, Moisio A-L, et al. DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary nonpolyposis colorectal cancer. Hum Mol Genet 1996;5:763-9.
13. Salovaara R, Loukola A, Kristo P, et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 2000;18:2193-200.
14. Jager AC, Bisgaard ML, Myrhoj T, et al. Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression. Am J Hum Genet 1997;61:129-38
15. Froggatt NJ, Green J, Brassett C, et al. A common MSH2 mutation in English and North American HNPCC families: Origin, phenotypic expression, and sex specific differences in colorectal cancer. J Med Genet 1999;36:97-102.
16. Desai DC, Lockman JC, Chadwick RB, et al. Recurrent germline mutation in MSH2 arises frequently de novo. J Med Genet 2000;37:646-52.
17. Eng C, Hampel H, de la CA. Genetic testing for cancer predisposition. Annu Rev Med 2001;52:371-400
18. Scott RJ, McPhillips M, Meldrum CJ, et al. Hereditary nonpolyposis colorectal cancer in 95 families: Differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 2001;68:118-27.
19. International Agency for Research on Cancer. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Lyon, France: International Agency for Research on Cancer, 2000. (World Wide Web URL: http://www.who.int).
20. International Agency for Research on Cancer. Cancer Incidence in Five Continents. Vol 7. (IARC Scientific Publication no. 143). Lyon, France: International Agency for Research on Cancer, 1997.
21. American Cancer Society. Cancer facts and figures 2002. New York, NY: American Cancer Society, 2002. (World Wide Web URL: http://www.cancer.org).
22. Parkin DM. Studies of cancer in migrant populations: Methods and interpretation. Rev Epidemiol Sante Publique 1992;40:410-24.
23. Potter JD (Chair). Food, Nutrition and the Prevention of Cancer: A Global Perspective. London, United Kingdom: World Cancer Research Fund, 2001. (World Wide Web URL: http:// www.wcrf.org.uk).
24. Potter JD. Colorectal cancer: Molecules and populations. J Natl Cancer Inst 1999;91:916-32.
25. Alberts DS, Martinez ME, Roe DJ, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med 2000;342:1156-62.
26. Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med 2000;342:1149-55.
27. Fuchs CS, Giovannucci EL, Colditz GA, et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 1999;340:169-76.
28. Rijnkels JM, Hollanders VM, Woutersen RA, et al. Absence of an inhibitory effect of a vegetables-fruit mixture on the initiation and promotion phases of azoxymethane-induced colorectal carcinogenesis in rats fed low- or high-fat diets. Nutr Cancer 1998;30:124-9.
29. van Kranen HJ, van Iersel PW, Rijnkels JM, et al. Effects of dietary fat and a vegetable-fruit mixture on the development of intestinal neoplasia in the ApcMin mouse. Carcinogenesis 1998;19:1597-601.
30. Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-16.
31. Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-52.
32. Giacosa A, Franceschi S, La Vecchia C, et al. Energy intake, overweight, physical exercise and colorectal cancer risk. Eur J Cancer Prev 1999;8(suppl 1):S53-60.
33. La Vecchia C, Negri E, Decarli A, et al. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1997;6:1007-10.
34. La Vecchia C, Negri E, Franceschi S, et al. Aspirin and colorectal cancer. Br J Cancer 1997;76:675-7.
35. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001;10:725-31.
36. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78-85.
37. Nystrom-Lahti M, Parsons R, Sistonen P, et al. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am J Hum Genet 1994;55:659-65.
38. Froggatt NJ, Koch J, Davies R, et al. Genetic linkage analysis in hereditary nonpolyposis colon cancer syndrome. J Med Genet 1995;32:352-7.
39. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-16.
40. Ionov Y, Peinado MA, Malkhosyan S, et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-61.
41. Strand M, Prolla TA, Liskay RM, et al. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 1993;365:274-6.
42. Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer. Nature 1994;368:258-61.
43. Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
44. Papadopoulos N, Nicolaides NC, Wei YF, et al. Mutation of a mutL homolog in hereditary colon cancer. Science 1994;263:1625-9.
45. Farrington SM, Lin-Goerke J, Ling J, et al. Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls. Am J Hum Genet 1998;63:749-59.
46. Samowitz WS, Curtin K, Lin HH, et al. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 2001;121:830-8.
47. Aarnio M, Sankila R, Pukkala E, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999;81:214-18.
48. Millar AL, Pal T, Madlensky L, et al. Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium. Hum Mol Genet 1999;8:823-9.
49. Boland CR. Molecular genetics of hereditary nonpolyposis colorectal cancer. Ann N Y Acad Sci 2000;910:50-9.
50. Bapat BV, Madlensky L, Temple LKF, et al. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer. Hum Genet 1999;104:167-76.
51. Debniak T, Kurzawski G, Gorski B, et al. Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer. Eur J Cancer 2000;36:49-54.
52. Liu T, Wahlberg S, Burek E, et al. Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer. Genes Chromosomes Cancer 2000;27:17-25.
53. Lin KM, Shashidharan M, Thorson AG, et al. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. J Gastrointest Surg 1998;2:67-71.
54. Vasen HF, Stormorken A, Menko FH, et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 2001;19:4074-80.
55. Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-7.
56. Dunlop MG, Farrington SM, Carothers AD, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105-10.
57. Heinimann K, Scott RJ, Buerstedde J-M, et al. Influence of selection criteria on mutation detection in patients with hereditary nonpolyposis colorectal cancer. Cancer 1999;85:2512-18.
58. Sankila R, Aaltonen LA, Jarvinen HJ, et al. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 1996;110:682-7.
59. Aebi S, Fink D, Gordon R, et al. Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells. Clin Cancer Res 1997;3:1763-7.
60. Carethers JM, Chauhan DP, Fink D, et al. Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology 1999;117:123-31.
61. Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance. Clin Cancer Res 1998;4:1-6.
62. Fujieda S, Tanaka N, Sunaga H, et al. Expression of hMSH2 correlates with in vitro chemosensitivity to CDDP cytotoxicity in oral and oropharyngeal carcinoma. Cancer Lett 1998;132:37-44.
63. Ruschoff J, Wallinger S, Dietmaier W, et al. Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc Natl Acad Sci U S A 1998;95:11301-6.
64. Yamamoto H, Itoh F, Fukushima H, et al. Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability. Int J Cancer 1999;84:400-3.
65. Slattery ML, Curtin K, Anderson K, et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000;92:1831-6.
66. Wu AH, Shibata D, Yu MC, et al. Dietary heterocyclic amines and microsatellite instability in colon adenocarcinomas. Carcinogenesis 2001;22:1681-4.
67. Slattery ML, Potter JD, Curtin K, et al. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 2001;61:126-30.
68. Canzian F, Ushijima T, Serikawa T, et al. Instability of microsatellites in rat colon tumors induced by heterocyclic amines. Cancer Res 1994;54:6315-17.
69. Moisio AL, Sistonen P, Mecklin JP, et al. Genetic polymorphisms in carcinogen metabolism and their association to hereditary nonpolyposis colon cancer. Gastroenterology 1998;115:1387-94.
70. Kong S, Amos CI, Luthra R, et al. Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res 2000;60:249-52.
71. Reitmair AH, Cai JC, Bjerknes M, et al. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumori-genesis. Cancer Res 1996;56:2922-6.
72. Toft NJ, Winton DJ, Kelly J, et al. Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine. Proc Natl Acad Sci U S A 1999;96:3911-15.
73. Markowitz S. TGF-beta receptors and DNA repair genes, coupled targets in a pathway of human colon carcinogenesis. Biochim Biophys Acta 2000;1470:M13-20.
74. Wijnen J, Vasen H, Khan PM, et al. Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradientgel electrophoresis. Am J Hum Genet 1995;56:1060-6.
75. Sasaki S, Tokino T, Miyatsu T, et al. Mutational analysis of the hMLH1 gene using an automated two-dimensional DNA typing system. Hum Mutat 1997;9:164-71.
76. Bubb VJ, Curtis LJ, Cunningham C, et al. Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer. Oncogene 1996;12:2641-9.
77. Yan H, Papadopoulos N, Marra G, et al. Conversion of diploidy to haploidy. Nature 2000;403:723-4.
78. Dunlop MG, Farrington SM, Nicholl I, et al. Population carrier frequency of hMSH2 and hMLH1 mutations. Br J Cancer 2000;83:1643-5.
79. Brown ML, Kessler LG. The use of gene tests to detect hereditary predisposition to cancer: Economic considerations. J Natl Cancer Inst 1995;87:1131-6.
80. Brown ML, Kessler LG. Use of gene tests to detect hereditary predisposition to cancer: What do we know about cost effectiveness? Int J Cancer 1996;69:55-7.
81. Coughlin SS, Miller DS. Public health perspectives on testing for colorectal cancer susceptibility genes. Am J Prev Med 1999;16:99-104.
82. Ponder BA. Costs, benefits and limitations of genetic testing for cancer risk. Br J Cancer 1999;80(suppl 1):46-50.
83. Terdiman JP, Conrad PG, Sleisenger MH. Genetic testing in hereditary colorectal cancer: Indications and procedures. Am J Gastroenterol 1999;94:2344-56.
84. Welch HG, Burke W. Uncertainties in genetic testing for chronic disease. JAMA 1998;280:1525-7.
85. Amos CI, Frazier ML, Wang W. DNA pooling in mutation detection with reference to sequence analysis. Am J Hum Genet 2000;66:1689-92.
86. Syngal S, Fox EA, Eng C, et al. Sensitivity and specificity of clinical criteria for hereditary nonpolyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet 2000;37:641-5.
87. Vasen HF, Mecklin JP, Khan PM, et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
88. Bellacosa A, Genuardi M, Anti M, et al. Hereditary nonpolyposis colorectal cancer: Review of clinical, molecular genetics, and counseling aspects. Am J Med Genet 1996;62:353-64.
89. Fujita S, Moriya Y, Sugihara K, et al. Prognosis of hereditary nonpolyposis colorectal cancer (HNPCC) and the role of Japanese criteria for HNPCC. Jpn J Clin Oncol 1996;26:351-5.
90. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997;89:1758-62.
91. European Network of Cancer Registries (EUCAN). Cancer Incidence, Mortality and Prevalence in the European Union. Lyon, France: International Agency for Research on Cancer, 1999.
92. Aarnio M, Mecklin JP, Aaltonen LA, et al. Life-time risk of different cancers in hereditary nonpolyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995;64:430-3.
93. Froggatt NJ, Brassett C, Koch DJ, et al. Mutation screening of MSH2 and MLH1 mRNA in hereditary nonpolyposis colon cancer syndrome. J Med Genet 1996;33:726-30.
94. Bai YQ, Akiyama Y, Nagasaki H, et al. Predominant germline mutation of the hMSH2 gene in Japanese hereditary nonpolyposis colorectal cancer kindreds. Int J Cancer 1999;82:512-15.
95. Buerstedde JM, Alday P, Torhorst J, et al. Detection of new mutations in six out of 10 Swiss HNPCC families by genomic sequencing of the hMSH2 and hMLH1 genes. J Med Genet 1995;32:909-12.
96. Calistri D, Presciuttini S, Buonsanti G, et al. Microsatellite instability in colorectal-cancer patients with suspected genetic predisposition. Int J Cancer 2000;89:87-91.
97. Curia MC, Palmirotta R, Aceto G, et al. Unbalanced germline expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancer. Cancer Res 1999;59:3570-5.
98. de Leon MP, Pedroni M, Benatti P, et al. Hereditary colorectal cancer in the general population: From cancer registration to molecular diagnosis. Gut 1999;45:32-8.
99. Dieumegard B, Grandjouan S, Sabourin J-C, et al. Extensive molecular screening for hereditary nonpolyposis colorectal cancer. Br J Cancer 2000;82:871-80.
100. Han H-J, Yuan Y, Ku J-L, et al. Germline mutations of hMLH1 and hMSH2 genes in Korean hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst 1996;88:1317-19.
101. Hutter P, Couturier A, Membrez V, et al. Excess of hMLH1 germline mutations in Swiss families with hereditary nonpolyposis colorectal cancer. Int J Cancer 1998;78:680-4.
102. Kohonen-Corish M, Ross VL, Doe WF, et al. RNA-based mutation screening in hereditary nonpolyposis colorectal cancer. Am J Hum Genet 1996;59:818-24.
103. Lamberti C, Kruse R, Ruelfs C, et al. Microsatellite instability - A useful diagnostic tool to select patients at high risk for hereditary nonpolyposis colorectal cancer: A study in different groups of patients with colorectal cancer. Gut 1999;44:839-43.
104. Liu T, Wahlberg S, Rubio C, et al. DGGE screening of mutations in mismatch repair genes (hMSH2 and hMLH1) in 34 Swedish families with colorectal cancer. Clin Genet 1998;53:131-5.
105. Luce MC, Marra G, Chauhan DP, et al. In vitro transcription/ translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer. Gastroenterology 1995;109:1368-74.
106. Maliaka YK, Chudina AP, Belev NF, et al. CpG dinucleotides in the hMSH2 and hMLH1 genes are hotspots for HNPCC mutations. Hum Genet 1996;97:251-5.
107. Miyaki M, Konishi M, Muraoka M, et al. Germ line mutations of hMSH2 and hMLH1 genes in Japanese families with hereditary nonpolyposis colorectal cancer (HNPCC): Usefulness of DNA analysis for screening and diagnosis of HNPCC patients. J Mol Med 1995;73:515-20.
108. Moslein G, Tester DJ, Lindor NM, et al. Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet 1996;5:1245-52.
109. Nomura S, Sugano K, Kashiwabara H, et al. Enhanced detection of deleterious and other germline mutations of hMSH2 and hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds. Biochem Biophys Res Commun 2000;271:120-9.
110. Pensotti V, Radice P, Presciuttini S, et al. Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes. Genes Chromosomes Cancer 1997;19:135-42.
111. Syngal S, Fox EA, Li C, et al. Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: Implications for clinical predisposition testing. JAMA 1999;282:247-53.
112. Tannergard P, Lipford JR, Kolodner R, et al. Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families. Cancer Res 1995;55:6092-6.
113. Wahlberg SS, Nystrom-Lahti M, Kane MF, et al. Low frequency of hMSH2 mutations in Swedish HNPCC families. (Letter). Int J Cancer 1997;74:134-7.
114. Wang Q, Desseigne F, Lasset C, et al. Germline hMSH2 and hMLH1 gene mutations in incomplete HNPCC families. Int J Cancer 1997;73:831-6.
115. Wang Y, Friedl W, Lamberti C, et al. A novel missense mutation in the DNA mismatch repair gene hMLH1 present among East Asians but not among Europeans. Hum Hered 1998;48:87-91.
116. Wijnen JT, Vasen HF, Khan PM, et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 1998;339:511-18.
117. Beck NE, Tomlinson IP, Homfray T, et al. Genetic testing is important in families with a history suggestive of hereditary nonpolyposis colorectal cancer even if the Amsterdam criteria are not fulfilled. Br J Surg 1997;84:233-7.
118. Yuan Y, Han HJ, Zheng S, et al. Germline mutations of hMLH1 and hMSH2 genes in patients with suspected hereditary nonpolyposis colorectal cancer and sporadic early-onset colorectal cancer. Dis Colon Rectum 1998;41:434-40.
119. Viel A, Genuardi M, Capozzi E, et al. Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer. Genes Chromosomes Cancer 1997;18:8-18.
120. Wang Q, Lasset C, Desseigne F, et al. Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer. Hum Genet 1999;105:79-85.
121. Fornasarig M, Viel A, Valentini M, et al. Microsatellite instability and MLH1 and MSH2 germline defects are related to clinicopathological features in sporadic colorectal cancer. Oncol Rep 2000;7:39-43.
122. Montera M, Resta N, Simone C, et al. Mutational germline analysis of hMSH2 and hMLH1 genes in early onset colorectal cancer patients. (Letter). J Med Genet (Online) 2000;37:E7.
123. Tomlinson IP, Beck NE, Homfray T, et al. Germline HNPCC gene variants have little influence on the risk for sporadic colorectal cancer. J Med Genet 1997;34:39-42.
124. Weber TK, Chin H-M, Rodriguez-Bigas M, et al. Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer. JAMA 1999;281:2316-20.
125. Fidalgo P, Almeida MR, West S, et al. Detection of mutations in mismatch repair genes in Portuguese families with hereditary nonpolyposis colorectal cancer (HNPCC) by a multi-method approach. Eur J Hum Genet 2000;8:49-53.